Juvena Therapeutics
A biopharmaceutical platform which is discovering novel protein-based therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD224—335m (Dealroom.co estimates Nov 2022.)
Palo Alto California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $4.3m | Seed | |
| N/A | N/A | Seed | |
N/A | - | ||
$3.9m | Grant | ||
* | $41.0m | Series A | |
| Total Funding | CAD67.1m | ||
Related Content
Recent News about Juvena Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.